Immuron Limited announced the submission of the Clinical Study Report for its Phase 2 clinical trial of Travelan® (IMM-124E) to the FDA, which demonstrated statistically significant immunological and ...
Activation of immune blood biomarkers from interferon gamma pathway distinguished long-term survivors (>=2 years) ...
TORONTO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative ...
Data from the BREADTH Phase 2b asthma trial is expected to be reported in late-2027. Data from the ongoing parallel BROADEN2 Phase 2b atopic dermatitis trial is expected to be rep ...
(RTTNews) - Quantum BioPharma Ltd. (QNTM), Tuesday announced that the company has received the clinical study report for the phase 1 multiple ascending dose trial of experimental multiple sclerosis ...
6don MSN
When patients report symptoms, clinicians can judge cancer treatment side effects more consistently
A large multinational clinical trial has found that giving health care providers access to European Organization for Research ...
Diabetic neuropathy is a common, progressive complication of diabetes characterized by nerve damage that leads to chronic ...
AstraZeneca's $15 billion pledge to its China operations highlights the country's advantages. But other regions are also hoping to host more clinical studies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results